EL7.AI
StocksMedium•27 July 2026•
1 min read

Philips Raises 2026 Outlook on Sales Growth and US Tariff Refund

Key Facts

1Philips achieved 4% comparable sales growth reaching EUR 4.4 billion in Q2 2026.
2The company raised its full-year Adjusted EBITA and free cash flow outlook to reflect a EUR 186 million US tariff refund.
3Adjusted EBITA margin increased to 16.4%, significantly bolstered by the tariff refund benefit.

In a move reflecting the financial resilience of major medical technology firms, Philips reported solid Q2 2026 results. The company achieved 4% comparable sales growth, reaching EUR 4.4 billion, driven by disciplined execution across all business segments. According to reports, a EUR 186 million US tariff refund significantly bolstered the results during this period.

The tariff refund helped push the company's Adjusted EBITA margin to 16.4%. Consequently, management raised its full-year outlook for Adjusted EBITA and free cash flow, despite a 1% decline in order intake attributed to timing issues. These results come as market data indicates relative stability within the industrial and healthcare sectors.

Regarding stock performance, PHG stood at $26.17 (close July 24, 2026), with a day high of $26.41. Traders are now monitoring the sustainability of this growth amid a shifting economic environment, with an eye on the Netherlands Consumer Confidence data scheduled for July 23, 2026, as a potential sentiment catalyst.